Reports of changes in contrast sensitivity in proliferative diabetic r
etinopathy (PDR) patients after panretinal photocoagulation (PRP) have
considered only relatively short-term results, and these have been co
nflicting. We evaluated contrast sensitivity changes in 30 eyes of 29
PDR patients after PRP The patients were divided into two groups. One,
group A, received PRP at one sitting, and the other, group B, at two
sittings. Before and at regular intervals after PRP all of the patient
s underwent a battery of macular function tests for best-corrected vis
ual acuity, color vision, contrast sensitivity, and photostress. Contr
ast sensitivity was significantly affected (P<.001) in both groups imm
ediately after PRP but stabilized to prelaser levels by the end of 3 m
onths. Color-vision-error scores also were significantly higher (P<.00
1) immediately after PRP Best-corrected Snellen visual acuity, however
, remained stable at prelaser levels. Contrast sensitivity appears to
provide a more sensitive measurement of visual acuity than the Snellen
chart for monitoring foveal integrity in patients undergoing PRP.